Polyol pathway-related skeletal muscle contractile and morphological abnormalities in diabetic rats

M A Cotter1, N E Cameron, S Robertson

  • 1Department of Biomedical Sciences, Marischal College, University of Aberdeen.

Insights

Aldose reductase inhibition helps prevent and reverse diabetic muscle damage. Treatment improved muscle function and structure in rats with diabetes, suggesting the polyol pathway contributes to myopathy.

Area of Science:

  • Biochemistry
  • Physiology
  • Endocrinology

Background:

  • Diabetes mellitus is associated with skeletal muscle dysfunction, termed diabetic myopathy.
  • The polyol pathway, particularly aldose reductase activity, is implicated in diabetic complications.

Purpose of the Study:

  • To investigate the role of aldose reductase inhibition in preventing and reversing diabetic myopathy in rat skeletal muscles.
  • To assess the impact of treatment on muscle morphology, function, and vascular supply.

Main Methods:

  • Streptozotocin-induced diabetes in rats.
  • Administration of aldose reductase inhibitors in preventative and reversal models.
  • Assessment of muscle contractile properties, fiber area, oxidative enzyme activity, and capillary-fiber ratio.

Main Results:

  • Diabetes prolonged soleus muscle contractions and slowed relaxation, with partial prevention and amelioration by treatment.
  • Tetanic tension in extensor digitorum longus was reduced by diabetes but antagonized by treatment.
  • Soleus fatigue resistance, oxidative enzyme staining, and capillary-fiber ratio improved with aldose reductase inhibition.

Conclusions:

  • Enhanced polyol pathway activity contributes to diabetic myopathy.
  • Aldose reductase inhibitors show potential in preventing and reversing diabetic muscle pathology by targeting muscle fibers and vascular supply.

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...